Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Gains from Investment Securities: 2009-2024

Historic Gains from Investment Securities for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to $1.4 million.

  • Pediatrix Medical's Gains from Investment Securities rose 4585.72% to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.6 million, marking a year-over-year increase of 4071.4%. This contributed to the annual value of $1.4 million for FY2024, which is 9540.58% down from last year.
  • Latest data reveals that Pediatrix Medical reported Gains from Investment Securities of $1.4 million as of FY2024, which was down 9540.58% from $30.8 million recorded in FY2023.
  • In the past 5 years, Pediatrix Medical's Gains from Investment Securities ranged from a high of $54.7 million in FY2021 and a low of -$27.8 million during FY2020
  • Its 5-year average for Gains from Investment Securities is $17.2 million, with a median of $26.9 million in 2022.
  • As far as peak fluctuations go, Pediatrix Medical's Gains from Investment Securities crashed by 13219.62% in 2020, and later soared by 29704.05% in 2021.
  • Annual analysis of 5 years shows Pediatrix Medical's Gains from Investment Securities stood at -$27.8 million in 2020, then soared by 297.04% to $54.7 million in 2021, then plummeted by 50.83% to $26.9 million in 2022, then increased by 14.59% to $30.8 million in 2023, then tumbled by 95.41% to $1.4 million in 2024.
  • Its Gains from Investment Securities stands at $1.4 million for FY2024, versus $30.8 million for FY2023 and $26.9 million for FY2022.